# Abbott Laboratories (ABT) — Q4-2019 Earnings Results

**Report date:** 2020-01-22 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2019

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 2.37%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.95 | N/A | +3.71% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported a stronger-than-expected EPS for the fourth quarter of 2019, which contributed to a positive stock reaction, with shares rising by 2.37%. The lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the EPS beat, but the absence of additional context makes it difficult to gauge the company's full financial health.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2019_